HydromorphoneMURRAY, Alison; HAGEN, Neil A.Journal of pain and symptom management. 2005, Vol 29, Num 5S, pp S57-S66, issn 0885-3924, SUPConference Paper

The status of naltrexone in the treatment of alcohol dependence : Specific effects on heavy drinkingPETTINATI, Helen M; O'BRIEN, Charles P; RABINOWITZ, Amanda R et al.Journal of clinical psychopharmacology. 2006, Vol 26, Num 6, pp 610-625, issn 0271-0749, 16 p.Article

An open trial of naltrexone in the treatment of depersonalization disorderSIMEON, Daphne; KNUTELSKA, Margaret.Journal of clinical psychopharmacology. 2005, Vol 25, Num 3, pp 267-270, issn 0271-0749, 4 p.Article

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophreniaPETRAKIS, Ismene L; O'MALLEY, Stephanie; ROUNSAVILLE, Bruce et al.Psychopharmacologia. 2004, Vol 172, Num 3, pp 291-297, issn 0033-3158, 7 p.Article

A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependenceBALLDIN, J; BERGLUND, M; WILLANDER, A et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 7, pp 1142-1149, issn 0145-6008, 8 p.Article

New therapeutic options for alcohol dependence : Long-acting intramuscular formulations of naltrexoneGARBUTT, James C.The Journal of clinical psychiatry. 2006, Vol 67, pp 30-34, issn 0160-6689, 5 p., SUP14Article

Antidotes : benefits and risksPROUDFOOT, A. T.Toxicology letters. 1995, Vol 82-83, pp 779-783, issn 0378-4274Conference Paper

NaloxoneLa Revue Prescrire. 1995, Vol 15, Num 156, issn 0247-7750, p. 741Article

Morphine and codeine from mammalian brainWEITZ, C. J; LOWNEY, L. I; FAULL, K. F et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 24, pp 9784-9788, issn 0027-8424Article

Synthesis and biological evaluation of 14-alkoxymorphinans. IV: Opioid agonists and partial opioid agonists in a series of N-(cyclobutylmethyl)-14-methoxymorphinan-6-onesSCHMIDHAMMER, H; BURKARD, W. P; EGGSTEIN-AEPPLI, L et al.Helvetica chimica acta. 1989, Vol 72, Num 6, pp 1233-1240, issn 0018-019X, 8 p.Article

Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatmentO'MALLEY, Stephanie S; GARBUTT, James C; GASTFRIEND, David R et al.Journal of clinical psychopharmacology. 2007, Vol 27, Num 5, pp 507-512, issn 0271-0749, 6 p.Article

Association of OPRM1 A118G variant with the relative reinforcing value of nicotineRAY, R; JEPSON, C; PATTERSON, F et al.Psychopharmacologia. 2006, Vol 188, Num 3, pp 355-363, issn 0033-3158, 9 p.Article

Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot studyCUCINELLI, Francesco; SORANNA, Liberato; PERRI, Concetta et al.Fertility and sterility. 2004, Vol 81, Num 4, pp 1047-1054, issn 0015-0282, 8 p.Article

Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative studyCAPUTO, F; ADDOLORATO, G; LORENZINI, F et al.Drug and alcohol dependence. 2003, Vol 70, Num 1, pp 85-91, issn 0376-8716, 7 p.Article

Hydromorphone : pharmacology and clinical applications in cancer patientsSARHILL, Nabeel; WALSH, Declan; NELSON, Kristine A et al.Supportive care in cancer. 2001, Vol 9, Num 2, pp 84-96, issn 0941-4355Article

Naltrexone for alcohol dependence: a randomized controlled trialMORRIS, Philip L. P; HOPWOOD, Malcolm; WHELAN, Greg et al.Addiction (Abingdon. Print). 2001, Vol 96, Num 11, pp 1565-1573, issn 0965-2140Article

Nalmefene hydrochlorideCHUMPA, A.Pediatric emergency care. 1999, Vol 15, Num 2, pp 141-143, issn 0749-5161Article

A randomized trial of naltrexone for smoking cessationWONG, G. Y; WOLTER, T. D; CROGHAN, G. A et al.Addiction (Abingdon. Print). 1999, Vol 94, Num 8, pp 1227-1237, issn 0965-2140Article

10-HydroxythebainePROKSA, B.Archiv der Pharmazie (Weinheim). 1999, Vol 332, Num 10, pp 369-370, issn 0365-6233Article

Chemiluminescence determination of naltrexone based on potassium permanganate oxidationCAMPIGLIO, A.Analyst (London. 1877. Print). 1998, Vol 123, Num 5, pp 1053-1056, issn 0003-2654Conference Paper

Adverse cardiac manifestations following dextropropoxyphene overdose : can naloxone be helpful ?HANTSON, P; EVENEPOEL, M; ZIADE, D et al.Annals of emergency medicine. 1995, Vol 25, Num 2, pp 263-266, issn 0196-0644Article

Applicaltion of the Mitsunobu reaction in the morphine series. Preparation of 6β-amino-14β-hydroxymorphine and 14-hydroxycodeine derivativesSIMON, C; HOSZTAFI, S; MAKLEIT, S et al.Heterocycles (Sendai). 1994, Vol 38, Num 6, pp 1347-1354, issn 0385-5414Article

Naltrexone renders one-session exposure therapy less effective : A controlled pilot studyKOZAK, Andrea T; SPATES, C. Richard; MCCHARGUE, Dennis E et al.Journal of anxiety disorders. 2007, Vol 21, Num 1, pp 142-152, issn 0887-6185, 11 p.Article

A cadillac ride to the emergency departmentOSTERHOUDT, Kevin C.Pediatric emergency care. 2005, Vol 21, Num 12, pp 877-879, issn 0749-5161, 3 p.Article

Differential effects of yohimbine, naloxone and 8-OH-DPAT on ejaculatory response in male dogsYONEZAWA, A; ANDO, R; IMAI, M et al.Methods and findings in experimental and clinical pharmacology. 2004, Vol 26, Num 1, pp 47-51, issn 0379-0355, 5 p.Article